Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Toronto

$25,000.00

Chemical biosensors for improving drug production

EF 2017-18

Résumé
Many pharmaceuticals are complex, natural compounds that can be difficult to extract from their sources or tosynthesize chemically. To overcome this, some pharmaceuticals can be produced in a host organism that iseasier to manage on a commercial scale. Hyasynth Bio has developed strains of yeast that producecannabinoids, a class of compounds with great potential as medicines and therapeutics. Early approvedcannabinoid medicines in Canada include nabiximols, for adjunctive analgesic treatment in adult patients withadvanced cancer, and nabilone, for severe nausea and vomiting associated with cancer chemotherapy. Torapidly screen yeast strains with improved cannabinoid production, a simple way of detecting and quantifyingthese compounds is required. We aim to develop a new means of detecting medicinal cannabinoids to improvetheir commercial production.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
519754-2017
Name nom
McMillen, David
Department département
Chemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Chemical biosensors for improving drug production
Keyword
NSERC
Application summary
Many pharmaceuticals are complex, natural compounds that can be difficult to extract from their sources or tosynthesize chemically. To overcome this, some pharmaceuticals can be produced in a host organism that iseasier to manage on a commercial scale. Hyasynth Bio has developed strains of yeast that producecannabinoids, a class of compounds with great potential as medicines and therapeutics. Early approvedcannabinoid medicines in Canada include nabiximols, for adjunctive analgesic treatment in adult patients withadvanced cancer, and nabilone, for severe nausea and vomiting associated with cancer chemotherapy. Torapidly screen yeast strains with improved cannabinoid production, a simple way of detecting and quantifyingthese compounds is required. We aim to develop a new means of detecting medicinal cannabinoids to improvetheir commercial production.